Daniel Soffer

Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome

Philippe Szapary, LeAnne T. Bloedon, Frederick F. Samaha et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 161 citations · Full text

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function

Catherine E. Watson, Nicole Weissbach, Lise Kjems et al. · Journal of Lipid Research · 2010 · 147 citations · Full text

Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association

Jennifer G. Robinson, Manju Bengularu Jayanna, Alan S. Brown et al. · Journal of clinical lipidology · 2019 · 56 citations

Clinical Immunology, Pcsk9 Monoclonal Antibodies, Medicine +10

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association

Daniel Soffer, Nicholas Marston, Kevin C. Maki et al. · Journal of clinical lipidology · 2024 · 53 citations · Full text

Metabolic Syndrome, Cardiovascular Epidemiology, Cardiovascular Disease +10

Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)

Vincent A. Pallazola, Vasanth Sathiyakumar, Jihwan Park et al. · Archives of Medical Science · 2019 · 34 citations · Full text